Small biotech trials face hidden supply risks that waste up to 75% of materials, delay timelines, and drain funding faster. Learn what causes them and how to prevent them.
- The RTSM–EDC Integration Trap: Why Broken Workflows Still Undermine Trial Execution
- Building Win-Win Partnerships In Clinical Trial Supply
- The NDC-12 Ripple Effect: Why Clinical Trial Supply Chains Must Act Seven Years Early
- Bridging Preclinical Science And Trial Supply Success
- The New Reality Of Clinical Trial Logistics
- Drug Shortages In Clinical Trials: A Policy Blueprint
- Leading Clinical Trial Supply Teams: Insights And Best Practices
- Designing Clinical Trials For Hard-To-Access Patients
ON-DEMAND WEBINARS
This webinar will offer best practices for UAT for sponsor organizations with the aim of changing the conversations and expectations around the UAT process.
Industry experts share insights to help you mitigate supply chain risk and accelerate access to novel cell and gene therapies.
Gain essential insights into QP roles, regulatory updates, and best practices for ensuring compliance, supply continuity, and safe handling of cold and frozen pharmaceutical products across the UK and EU.
Learn about supply strategy optimization while balancing the importance of remaining site-centric in this webinar.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![iStock-1219082584-delivery-direct-logistics]( "How Direct-To-Patient Models Can Provide Clinical Supply Chains With An End-To-End Solution")
How Direct-To-Patient Models Can Provide Clinical Supply Chains With An End-To-End SolutionAnalyze the benefits and challenges of implementing direct-to-patient services in the clinical supply chain to help meet patient requirements, improve supply chain efficiency, and accelerate speed to market.
-
![gettyimages-946264212-170667a]( "Navigate Complex Ancillary Supply Sourcing Challenges")
Navigate Complex Ancillary Supply Sourcing ChallengesExplore the evolvement of the clinical trial landscape over recent years, as well as the new challenges that this poses for the clinical supply chain.
-
![West Pharma]( "Key Considerations For Packaging Solutions For Cell And Gene Therapies")
Key Considerations For Packaging Solutions For Cell And Gene TherapiesThinking of packaging and delivery factors early and often will minimize risks to the safety and efficacy of your cell and gene therapy drug product from the bench to the patient.
-
![GettyImages-1253545551-OSD-pill-tablet-oral-solid-dose]( "Development And Manufacture Of A Highly Potent OSD Product")
Development And Manufacture Of A Highly Potent OSD ProductHighly potent drug compounds require advanced containment and robust technical transfer protocols. CDMOs overcome challenges through meticulous testing, specialized tooling, and strong supplier relationships.
-
![GettyImages-980809416 clinical supply]( "Consolidating Clinical Supply Chain Operations With GxP Inventory")
Consolidating Clinical Supply Chain Operations With GxP InventoryA Japan-based biotechnology company leveraged Signant SmartSignals® GxP Inventory, which improved visibility, reduced risks and costs, and optimized operations in this case study.
-
![GettyImages-1316775813-vial-production]( "Build A Vial-Stopper Combination Suitable For Drug Product Storage At -80°C")
Build A Vial-Stopper Combination Suitable For Drug Product Storage At -80°CThis study worked to determine if the chosen vial-stopper-seal combination will remain integral while frozen at -80°C, under studied conditions, when the appropriate materials, processing, and sealing conditions are applied.
-
![GettyImages-2170642314-year 2025]( "What Does 2025 Hold For Pharma?")
What Does 2025 Hold For Pharma?Look at what’s in store for pharma and life science in 2025. While we see many recurring themes, 2025 promises to be filled with unexpected — and possibly unprecedented — developments.
-
![GettyImages-2162599103-tablet-pen-graphs-data]( "Analytics–Powered Approach To Patient Recruitment Strategy")
Analytics–Powered Approach To Patient Recruitment StrategyIn a Phase 3 psychiatry trial, a pharmaceutical company partnered with Signant to revolutionize patient recruitment through data-driven site selection using PureSignal Analytics.
-
![GettyImages-527547688 spreadsheet]( "Transforming Clinical Supply Planning From Spreadsheets To Smart Forecasting")
Transforming Clinical Supply Planning From Spreadsheets To Smart ForecastingStreamline your clinical supply forecasting and reduce risk by moving beyond manual spreadsheets to an integrated, real-time supply management solution.
-
![An Insider’s Guide To Interactive Response Technology (IRT) For Clinical Trials]( "What To Look For In Your IRT/RTSM Solution For A Simpler Trial Execution")
What To Look For In Your IRT/RTSM Solution For A Simpler Trial ExecutionWhich factors should you consider when selecting an IRT/RTSM vendor to ensure your trial's randomization and supply management processes are successfully executed?
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
